Literature DB >> 31556570

Risk factors for Alzheimer's disease.

Richard A Armstrong1.   

Abstract

Early reviews identified over 20 risk factors associated with Alzheimer's disease (AD) including age, familial inheritance, exposure to aluminium, traumatic brain injury (TBI), and associated co-morbidities such as vascular disease and infection. In the light of recent evidence, this review reconsiders these risk factors, identifies those currently regarded as important, and discusses various hypotheses to explain how they may cause AD. Rare forms of early-onset familial AD (EO-FAD) are strongly linked to causal gene mutations, viz. mutations in amyloid precursor protein (APP) and presenilin (PSEN1/2) genes. By contrast, late-onset sporadic AD (LO-SAD) is a multifactorial disorder in which age-related changes, genetic risk factors, such as allelic variation in apolipoprotein E (Apo E) and many other genes, vascular disease, TBI and risk factors associated with diet, the immune system, mitochondrial function, metal exposure, and infection are all implicated. These risk factors may act collectively to cause AD pathology: 1) by promoting the liberation of oxygen free radicals with age, 2) via environmental stress acting on regulatory genes early and later in life ('dual hit' hypothesis), or 3) by increasing the cumulative 'allostatic load' on the body over a lifetime. As a consequence, life-style changes which reduce the impact of these factors may be necessary to lower the risk of AD.

Entities:  

Keywords:  aging; allostatic load; environmental factors; genetics; risk factors; Alzheimer's disease (AD)

Mesh:

Substances:

Year:  2019        PMID: 31556570     DOI: 10.5114/fn.2019.85929

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  62 in total

Review 1.  Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Authors:  Anna Morozova; Yana Zorkina; Olga Abramova; Olga Pavlova; Konstantin Pavlov; Kristina Soloveva; Maria Volkova; Polina Alekseeva; Alisa Andryshchenko; Georgiy Kostyuk; Olga Gurina; Vladimir Chekhonin
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 2.  Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review.

Authors:  Hannah W Haddad; Garett W Malone; Nicholas J Comardelle; Arielle E Degueure; Salomon Poliwoda; Rachel J Kaye; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-07-28

3.  Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.

Authors:  Hannah W Haddad; Garett W Malone; Nicholas J Comardelle; Arielle E Degueure; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-01-30

Review 4.  Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders?

Authors:  Zhang Fan; Li Bin
Journal:  Front Cell Neurosci       Date:  2022-06-22       Impact factor: 6.147

5.  Alzheimer's Disease Association with Metals and Metalloids Concentration in Blood and Urine.

Authors:  Loreta Strumylaite; Rima Kregzdyte; Odeta Kucikiene; Dale Baranauskiene; Vaida Simakauskiene; Rima Naginiene; Gyte Damuleviciene; Vita Lesauskaite; Reda Zemaitiene
Journal:  Int J Environ Res Public Health       Date:  2022-06-14       Impact factor: 4.614

6.  REPS1 as a Potential Biomarker in Alzheimer's Disease and Vascular Dementia.

Authors:  Jiefeng Luo; Liechun Chen; Xiaohua Huang; Jieqiong Xie; Chun Zou; Mika Pan; Jingjia Mo; Donghua Zou
Journal:  Front Aging Neurosci       Date:  2022-06-22       Impact factor: 5.702

Review 7.  Low copper-2 intake in Switzerland does not result in lower incidence of Alzheimer's disease and contradicts the Copper-2 Hypothesis.

Authors:  Marc Solioz
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-16

8.  Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.

Authors:  Takumi Ashizawa; Ataru Igarashi; Yukinori Sakata; Mie Azuma; Kenichi Fujimoto; Tsukasa Kobayashi; Yoshimasa Takase; Shunya Ikeda
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 9.  Vitamin K2 Holds Promise for Alzheimer's Prevention and Treatment.

Authors:  Alexander Popescu; Monica German
Journal:  Nutrients       Date:  2021-06-27       Impact factor: 5.717

10.  Diacylglycerol Lipase-β Knockout Mice Display a Sex-Dependent Attenuation of Traumatic Brain Injury-Induced Mortality with No Impact on Memory or Other Functional Consequences.

Authors:  Lesley D O'Brien; Terry L Smith; Giulia Donvito; Benjamin F Cravatt; Jason Newton; Sarah Spiegel; Thomas M Reeves; Linda L Phillips; Aron H Lichtman
Journal:  Cannabis Cannabinoid Res       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.